Dr. Mitchell I. Chorost, MD

  • Roslyn, NY
  • Surgical oncologist
NPI1356397244PAC ID1153301056
Medicare services, 2024
789
Medicare patients, 2024
432
Part D claims, 2024
40
Publications
16
Clinical trials
1
Practice address
100 Port Washington Boulevard, Roslyn, NY 11576
Practice phone
Call (516) 562-6000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

St. Francis Hospital & Heart Center

Hospital · Roslyn, New York

See all 6 affiliations

Find Dr. Chorost's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mitchell I. Chorost is a surgical oncologist in Roslyn, New York

Dr. Chorost practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Dr. Chorost's NPI, 1356397244, was assigned on May 25, 2006. Dr. Chorost graduated from Rutgers New Jersey Medical School in 1993. Dr. Chorost holds New York license 205781.

NPI and contact details
Medicare PAC ID
1153301056
NPI enumeration date
May 25, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(516) 562-6000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
59
Medical school graduation
1993

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mitchell I. Chorost practices at St. Francis Hospital & Heart Center in Roslyn, New York

Dr. Chorost's primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Source: Dmand AI Affiliation Data

Dr. Mitchell I. Chorost is affiliated with 4 sites of care and 2 medical groups

Dr. Chorost's primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. Dr. Chorost is also affiliated with Good Samaritan University Hospital. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Chorost to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Chorost

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mitchell I. Chorost's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chorost practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
St. Francis Hospital & Heart CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Chorost practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Diocese of Rockville Centre and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mitchell I. Chorost is one of 162 surgical oncologists in New York

Surgical oncology is Dr. Chorost's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Chorost is board certified in surgery by the American Board of Surgery. Dr. Chorost is licensed in New York.

Specialties and state licenses

  • Surgical oncology, New YorkPrimaryLicense 205781 · 1997 to 2026 · taxonomy 2086X0206X

Clinical focus

Dmand AI lists abdominal adhesion surgery, colon removal and mastectomy among the conditions Dr. Chorost treats.

Surgical oncologists near Dr. Chorost

Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mitchell I. Chorost billed Medicare for 789 services in 2024

CMS data shows 789 Medicare services from Dr. Chorost across 14 procedure codes in 2024, for 432 Medicare patients. Medicare paid $114,703 for them.

Medicare services, 2024789
Medicare patients432
Paid by Medicare$114,703
Procedure codes14

Dr. Chorost's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5712024: 5914%
Surgery
2023: 872024: 10116%
Imaging
2023: 762024: 794%
Other services
2023: 02024: 18

Where Dr. Chorost's Medicare services took place, 2024

  • In an office32341%
  • In a facility46659%

Dr. Chorost compared with the New York median for surgical oncologists, 2024

  • Dr. Chorost
  • New York median
Medicare services
789vs 1246.4 times
Medicare patients
432vs 964.5 times
Part D claims
33vs 152.2 times

Medians across 145 surgical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Chorost's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Chorost

Need commercial claims for Dr. Chorost?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Chorost and other surgical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mitchell I. Chorost treated 432 Medicare patients in 2024, average age 76

CMS counts 432 Medicare patients who saw Dr. Chorost in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chorost's median patient age at 68, with 52% women.

Medicare patients, 2024432
Average age76
Average risk score1.77
Also on Medicaid14%

Dr. Chorost's Medicare patients by age, 2024

Dr. Chorost's Medicare patients by sex, 2024

  • Women23655%
  • Men19645%

Chronic conditions among Dr. Chorost's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Ischemic heart disease56%
  4. Arthritis55%
  5. Diabetes44%
  6. Atrial fibrillation37%
  7. Cancer36%
  8. Chronic kidney disease35%

Share of Medicare patients with each condition. A patient can have several.

Dr. Chorost's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women52%
  • Men46%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mitchell I. Chorost wrote 40 Medicare Part D claims in 2024

In 2024, Dr. Chorost wrote 40 Medicare Part D claims for 28 patients. 100% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $173 in total drug cost.

Part D claims, 202440
Drugs named by CMS2
Total drug cost$173
Part D patients28

Dr. Chorost's most prescribed drugs by claims, 2018

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Chorost's Part D claims, 2024

  • Antibiotics45%18 of 40 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

See all prescribing by Dr. Chorost

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mitchell I. Chorost ranks in the 87th percentile for melanoma (skin cancer) excision in Medicare

Dr. Chorost accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 51 procedures of melanoma (skin cancer) excision by Dr. Chorost, more than 87% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Where Dr. Chorost ranks in Medicare procedure volume

Melanoma (skin cancer) excision
87th percentile51 procedures
Mastectomy
78th percentile20 procedures
Removal of tissue
63rd percentile12 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find surgical oncologists like Dr. Chorost by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mitchell I. Chorost has 16 publications on record

Dmand AI links 16 papers to Dr. Chorost, published from 2006 to 2020. The most frequent topics are Postoperative Complications, Cholecystectomy and Delirium. Dr. Chorost's most frequent co-authors are Evan Brad Goldstein, DO, Sergei A. Aksenov, MD and Patrick I. Borgen, MD.

Papers16
Years published2006 to 2020

Dr. Chorost's papers by year, 2006 to 2020

Topics Dr. Chorost writes about most

  • Postoperative Complications
  • Cholecystectomy
  • Delirium
  • Guideline Adherence

Dr. Chorost's most frequent co-authors

Recent publications by Dr. Chorost

See all 16 publications and co-authors

See who Dr. Chorost researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Chorost works with, so you can find a warm path to the right surgical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mitchell I. Chorost has worked on 1 clinical trial

Dmand AI links Dr. Chorost to 1 clinical trial. Conditions studied include Acute-Phase Reaction and Delirium.

Conditions in Dr. Chorost's trials

  • Acute-Phase Reaction
  • Delirium

Recent clinical trials with Dr. Chorost

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Mitchell I. Chorost received $8,576 in industry payments from 2016 to 2025

CMS Open Payments shows 64 general payments to Dr. Chorost from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Cardinal Health, Inc. paid the most, $4,900.

General payments to Dr. Chorost by program year, 2016 to 2025

General payments to Dr. Chorost by kind, 2016 to 2025

$8.6Kin total
  • Consulting fees$6,11371%
  • Food and beverage$2,46329%

Companies that paid Dr. Chorost the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Chorost

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mitchell I. Chorost has 3 awards and honors on record

Dmand AI lists 3 awards for Dr. Chorost, most recently Regional Top Doctor in 2018.

Awards and honors for Dr. Chorost

  1. 2018
    • Regional Top Doctor
  2. 2013
    • CMS Stage 1 EHR
  3. 2011
    • ACS Fellow

Source: Dmand AI Professional Profile Data

Dr. Mitchell I. Chorost graduated from Rutgers New Jersey Medical School

Dr. Chorost graduated from Rutgers New Jersey Medical School in 1993. Dr. Chorost is a member of ACS.

  1. Medical schoolRutgers New Jersey Medical School
  2. Board certified in surgeryAmerican Board of Surgery

Source: Dmand AI Professional Profile Data

Dr. Mitchell I. Chorost accepts plans from 15 insurance carriers

Dr. Chorost is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • HCSC
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • Cigna
  • +7 more carriersWith a free account

Plan types Dr. Chorost accepts, by number of carriers

  1. PPO10
  2. Medicare9
  3. HMO7
  4. POS5
  5. EPO4
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Mitchell I. Chorost's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mitchell I. Chorost

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mitchell I. Chorost's NPI number?

Dr. Mitchell I. Chorost's NPI number is 1356397244. It was assigned on May 25, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mitchell I. Chorost?

Dr. Mitchell I. Chorost is a surgical oncologist in Roslyn, New York. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).

Where does Dr. Mitchell I. Chorost practice?

Dr. Chorost practices at 100 Port Washington Boulevard, Roslyn, NY 11576. Dr. Chorost's primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. Dmand AI also links Dr. Chorost to 1 group practice or clinic, 1 home health agency and 1 medical group.

What is Dr. Mitchell I. Chorost's office phone number?

The practice phone on file for Dr. Chorost is (516) 562-6000.

What is Dr. Mitchell I. Chorost's medical license number?

Dr. Chorost holds New York license 205781.

Which hospitals is Dr. Mitchell I. Chorost affiliated with?

Dr. Chorost practices at St. Francis Hospital & Heart Center in Roslyn, New York. Dr. Chorost is also affiliated with Good Samaritan University Hospital.

What medical group is Dr. Mitchell I. Chorost part of?

Dr. Chorost is linked to Cardiac Interventional Group. Dmand AI links Dr. Chorost to 1 more medical group.

Does Dr. Mitchell I. Chorost accept Medicare?

Yes. CMS data shows Dr. Chorost billed Medicare for 789 services in 2024, and Dr. Chorost accepts Medicare assignment.

How many Medicare patients does Dr. Mitchell I. Chorost see?

CMS counts 432 Medicare patients who saw Dr. Chorost in 2024, with an average age of 76.

Is Dr. Mitchell I. Chorost board certified?

Yes. Dr. Chorost is board certified in surgery by the American Board of Surgery.

Show 8 more questionsShow fewer questions

What services does Dr. Mitchell I. Chorost bill to Medicare?

In 2024, Dr. Chorost's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99214) and office visit, new patient (99204).

Where did Dr. Mitchell I. Chorost go to medical school?

Dr. Chorost graduated from Rutgers New Jersey Medical School in 1993.

What drugs does Dr. Mitchell I. Chorost prescribe most?

In 2018 Medicare Part D data, Dr. Chorost's most prescribed drugs by claims were Metronidazole and Neomycin Sulfate.

Has Dr. Mitchell I. Chorost received payments from drug or device companies?

CMS Open Payments shows $8,576 in general payments to Dr. Chorost from 19 companies from 2016 to 2025. The largest total came from Cardinal Health, Inc.

How long has Dr. Mitchell I. Chorost been practicing?

Dr. Chorost graduated from medical school in 1993, 33 years ago.

Does Dr. Mitchell I. Chorost do research?

Dmand AI links 16 publications to Dr. Chorost, published from 2006 to 2020. Dr. Chorost has worked on 1 clinical trial.

Who does Dr. Mitchell I. Chorost publish with?

Dr. Chorost's most frequent co-authors are Evan Brad Goldstein, DO (2 shared papers), Sergei A. Aksenov, MD (1 shared paper) and Patrick I. Borgen, MD (1 shared paper).

What insurance does Dr. Mitchell I. Chorost accept?

Dr. Chorost is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.

Selling to surgical oncology practices?

See surgical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)